Bill Summary
HB 309 Controlled Substances (2026 Session)
Bankson, Plakon Co Sponsors: Grow, López CS Sponsors: Criminal Justice Subcommittee, Justice Budget Subcommittee
Controlled Substances: Excepts from list of Schedule I controlled substances certain xylazine animal drug products approved by United States Food & Drug Administration & used for certain purposes; provides criminal penalties & requires mandatory minimum term of imprisonment if person sells, manufactures, or delivers or possesses with intent to sell, manufacture, or deliver xylazine; creates offense of trafficking in xylazine; provides criminal penalties & requires mandatory minimum term of imprisonment & fines based on quantity of controlled substance involved in offense. Effective Date: October 1, 2026
11/04/25
HOUSE
Filed
11/12/25
HOUSE
Referred to Criminal Justice Subcommittee; Justice Budget Subcommittee; Judiciary Committee
11/12/25
HOUSE
Now in Criminal Justice Subcommittee
01/15/26
HOUSE
On Committee agenda - Criminal Justice Subcommittee, 01/20/26, 9:30 am, 404 H
01/20/26
HOUSE
Favorable with CS by Criminal Justice Subcommittee; 15 Yeas, 1 Nay
01/20/26
HOUSE
Committee Substitute Text (C1) Filed
01/21/26
HOUSE
Now in Justice Budget Subcommittee
02/10/26
HOUSE
On Committee agenda - Justice Budget Subcommittee, 02/12/26, 8:00 am, 314 H - PCS
02/12/26
HOUSE
Favorable with CS by Justice Budget Subcommittee; 14 Yeas, 0 Nays
02/12/26
HOUSE
Committee Substitute Text (C2) Filed
02/13/26
HOUSE
Now in Judiciary Committee
02/20/26
HOUSE
On Committee agenda - Judiciary Committee, 02/24/26, 8:30 am, 404 H
02/24/26
HOUSE
Favorable by Judiciary Committee; 16 Yeas, 0 Nays
02/24/26
HOUSE
Placed on Calendar, on 2nd reading
893.03
893.13
893.135
Revenue Estimating Coverence Reports, Veto, Transmittal letters and more. Learn more.
No reports related to this bill.
Florida's most comprehensive legislative calendar.
Learn more.
- House Session
March 3, 2026 - Chamber
Related Press Announcements. Learn more.
Features above are available to LobbyTools subscribers.
Request a free demo or call (850) 915-0100 ext. 2 to learn more.
